Options
Animal Health

Development of an Alphavirus Replicon Classical Swine Fever Virus Vaccine Candidate

Authors
  • J. Dustin Loy (Iowa State University)
  • Mark Mogler (Iowa State University)
  • Jill Gander (Harrisvaccines, Inc.)
  • Kurt I. Kamrud (Iowa State University)
  • D.L. Hank Harris (Iowa State University)

Abstract

Classical swine fever virus (CSFV) E2 glycoprotein was expressed in an alphavirus based replicon expression system. Vaccinated pigs developed CSFV-specific antibodies. This is the first known use of this technology against CSFV.

Keywords: ASL R2752

How to Cite:

Loy, J., Mogler, M., Gander, J., Kamrud, K. I. & Harris, D. H., (2013) “Development of an Alphavirus Replicon Classical Swine Fever Virus Vaccine Candidate”, Iowa State University Animal Industry Report 10(1). doi: https://doi.org/10.31274/ans_air-180814-1256

Downloads:
Download pdf

310 Views

110 Downloads

Published on
2013-01-01

License

Creative Commons Attribution-NonCommercial 4.0